GE HealthCare Collaborates with Elekta to Expand Access to Precision Radiation Therapy Solutions in India

GE HealthCare Collaborates with Elekta to Expand Access to Precision Radiation Therapy Solutions in India

A collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy

 

Bengaluru, July 06, 2023: GE HealthCare, a leading global medical technology, diagnostics, and digital solutions innovator extends its collaboration with Elekta, a leader in radiation therapy, in the Indian market, to expand access to precision radiation therapy solutions. It aims to provide hospitals with a comprehensive offering across diagnostics and treatment for cancer patients who require radiation therapy.

Radiation therapy is an important component of cancer treatment with more than 50% of patients requiring radiotherapy as part of cancer care.[1] The World Health Organization (WHO) recommends one medical linear accelerator, (a radiotherapy equipment used in treating cancers) per million population in developing countries. India currently only has availability of  0.4 per million people reducing access to quality care necessary to enhance patient outcomes. Combining GE HealthCare diagnostic solutions with Elekta radiation therapy solutions will result in a compelling offering for hospitals and ultimately, their patients.

 

In-frame (from left to right) Chaitanya Sarawate, President & CEO, GE HealthCare South Asia and Managing Director, Wipro GE Healthcare: Manikandan Bala, Senior Vice President, TIMEA & Asia Pacific and Managing Director, India & South Africa, Elekta

 

“We continue to expand our oncology offerings through strategic collaborations in adjacent fields that are also leaders in their disciplines. Through this collaboration with Elekta our vision is to enable more efficient, precise and personalized care across the cancer care continuum. We will remain focused on investments that can deliver the best cancer care, offering solutions that transform and humanize care,” said Chaitanya Sarawate, President & CEO, GE HealthCare South Asia and Managing Director, Wipro GE Healthcare.”

 

GE HealthCare continues to embolden its commitment to providing an ecosystem where cancer care is improved by strengthening several collaborations. Over the years, the company has brought together complementary solutions and technologies along the radiation therapy treatment pathway. GE HealthCare’s collaboration with Elekta in India is a testament to the company’s commitment to improving cancer outcomes with multiple partners and providers.

 

Manikandan Bala, Senior Vice President, TIMEA & Asia Pacific and Managing Director, India & South Africa, Elekta, said, “Delivering precision radiation therapy requires advanced patient positioning, motion management technologies, and state-of-the-art radiation therapy techniques. Elekta’s and GE HealthCare’s combination of radiation therapy solutions and diagnostic imaging  will enable healthcare providers to deliver precise and personalized therapies that treat tumors effectively while sparing adjacent tissue and organs at risk. Together, these advanced offerings are designed to improve outcomes and increase the quality of life for patients. Elekta strives to assure that hospitals and cancer centers can create seamless ecosystems that facilitate efficient end-to-end cancer care.”

 

As a leading innovator of precision radiation therapy solutions, Elekta’s treatment modalities demand superior precision and accuracy in delivering radiation to the tumor while protecting surrounding healthy tissue and organs. GE HealthCare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational efficiency, and outcomes for cancer patients.

 

*GE HealthCare and Elekta will continue to offer their own solutions using standard interoperability and facilitate interfaces with any vendor’s systems. The agreement is non-exclusive, meaning each party can continue to co-operate with other partners.

 

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits. Follow us on Facebook, LinkedIn, Twitter and Insights for the latest news, or visit our website www.gehealthcare.in for more information.

 

About Wipro GE Healthcare Pvt. Ltd.

Wipro GE Healthcare Private Limited is a Joint Venture (JV) between GE Precision Healthcare LLC, USA, and Wipro Enterprises Limited, India. Established in 1990, it is one of the most successful and longest-running JVs in the region with operations spread across India, Bangladesh, Sri Lanka, Nepal, Maldives and Bhutan. The company is one of the most premium Medical Technology players in the South Asia region. Wipro GE Healthcare is focused on addressing some of the toughest healthcare challenges - helping lower maternal and infant deaths, enabling early detection of cancer, providing precision-care pathways for heart diseases , and driving better outcomes for trauma patients, among others.

 

About Elekta

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven, and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

 

Media contact

Shipra Singh | shipra.singh@ge.com | +91 9769496988